Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Meribank Biotech Co Ltd (4724) Income Statement

Meribank Biotech Co Ltd Income Statement

Last quarter (Q2 2026), Meribank Biotech Co Ltd's total revenue was NT$187.13M, an increase of 43.59% from the same quarter last year. In Q2, Meribank Biotech Co Ltd's net income was NT$-72.67M. See Meribank Biotech Co Ltd’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 471.76MNT$ 366.43MNT$ 234.34MNT$ 180.12MNT$ 163.08M
NT$ 202.18MNT$ 193.94MNT$ 138.87MNT$ 94.77MNT$ 90.06M
NT$ 254.96MNT$ 280.61MNT$ 262.02MNT$ 205.14MNT$ 187.27M
Depreciation and AmortizationNT$ 155.41MNT$ 84.02MNT$ 36.54MNT$ 32.16MNT$ 29.47M
NT$ 102.63MNT$ -6.83MNT$ -92.56MNT$ -64.66MNT$ -68.60M
NT$ -52.78MNT$ -86.67MNT$ -123.15MNT$ -109.78MNT$ -97.22M
NT$ -36.16MNT$ -14.88MNT$ -6.79MNT$ 6.56MNT$ -1.97M
NT$ -88.94MNT$ -101.55MNT$ -129.95MNT$ -103.23MNT$ -99.19M
NT$ -81.47MNT$ -94.71MNT$ -125.35MNT$ -102.13MNT$ -99.19M
Per Share Metrics
Basic EPSNT$ -0.89NT$ -1.19NT$ -1.99NT$ -1.62NT$ -1.63
Diluted EPSNT$ -0.89NT$ -1.19NT$ -1.99NT$ -1.62NT$ -1.63
Weighted Average Shares Outstanding91.33M79.59M62.99M63.18M60.98M
Weighted Average Shares Outstanding (Diluted)91.33M79.59M62.99M63.18M60.98M

Currency in TWD

Meribank Biotech Co Ltd Earnings and Revenue History

-300M0300M600M-75 %-50 %-25 %0 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin